Manufacturer record
Helax Health Care Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
17 batches manufactured by Helax Health Care Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between November 2019 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
17 records linked to Helax Health Care Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| TELMISARTAN TAB I.P. 40 MG. | GT-25044Mfg 2025-05 · Exp 2027-04 | The sample does not conform to I.P.Other | SDTL, Kolkata, West BengalState lab | May 2026 |
| TELMISARTAN TAB I.P. 40 MG. | GT-25043Mfg 2025-05 · Exp 2027-04 | The sample does not conform to I.P.Other | SDTL, Kolkata, West BengalState lab | May 2026 |
| Itraconazole Capsules BP 65 mg. | HC-2507123Mfg 2025-07 · Exp 2027-06 | The sample does not conform to claim as per B.P. with respect to the test for "Assay" and "Dissolution" of ItraconazoleAssay | RDTL, GuwahatiCDSCO lab | May 2026 |
| Telmisartan Tab I.P 40 mg | GT-2508Mfg 2025-03 · Exp 2027-02 | SAMPLE DOES NOT CONFIRM TO IP.Other | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15State lab | Apr 2026 |
| Metjeel 25 XL ( Metoprolol Succinate Prolonged Released Tablet I.P ) | TN - 5974Mfg 2025-09 · Exp 2027-08 | 1) SAMPLE DOES NOT CONFIRM TO IP. 2) The sample strip shows the product name " METJEEL 25XL" where the inspection memo shows it "Meetjeel 25XL"Other | Directorate of State Drugs Control & Research Laboratory ,2 , Convent Lane, Kol-15State lab | Apr 2026 |
| L-Methyl Folate, Pyridoxal-5 Phosphate & Methylcobalamin Tablets | HT-24011133Mfg 2024-11 · Exp 2026-10 | Test for Uniformity of WeightUniformity of weight/content | RDTL, Hubli, KarnatakaState lab | Mar 2026 |
| Telmisartan Tablets I.P. 40 mg | GT-2503Mfg 2025-03 · Exp 2027-02 | The sample does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Dec 2025 |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240203Mfg 2024-11 · Exp 2026-10 | Dissolution and AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240202Mfg 2024-11 · Exp 2026-10 | Dissolution and AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240219Mfg 2024-11 · Exp 2026-10 | Dissolution and AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240204Mfg 2024-11 · Exp 2026-10 | Dissolution and AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| TELMISARTAN TAB I.P. 40 MG. | GT-2502Mfg 2025-03 · Exp 2027-02 | DescriptionDescription | SDTL, Kolkata, West BengalState lab | Sep 2025 |
| TELMISARTAN TAB I.P. 40 MG. | GT-2504Mfg 2025-03 · Exp 2027-02 | DescriptionDescription | SDTL, Kolkata, West BengalState lab | Sep 2025 |
| Dapagliflozin Tablets IP (DAPAWOHN) | HT2406181Mfg 2024-06 · Exp 2026-05 | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab | May 2025 |
| Dapagliflozin Tablets IP (DAPAWOHN) | HT2406181Mfg 2024-06 · Exp 2026-05 | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab | May 2025 |
| Aceclofenac & Paracetamol Tablets (A-Sid Tablets) | HT-2401253Mfg 2024-12 · Exp 2026-11 | (1)The sample received is labelled as Aceclofenac & Paracetamol Tablets, however Aceclofenac & Paracetamol Tablets is an official IP monograph (Addendum 2024) hence should be labelled as Aceclofenac & Paracetamol Tablets IP. (2)For the received sample, Discolouration was observed. (3) Does not comply with respect to test for Uniformity of weight and Assay for Aceclofenac and ParacetamolAssay | State lab , PuducherryState lab | May 2025 |
| Prebiotic and Probitic Capsules (REPURE CAPSULES) | HC-1805016Mfg 2018-05 · Exp 2020-04 | Uniformity of filled WeightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Nov 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.